Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
23.37
+0.99 (4.42%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.07 billion as of October 9, 2026. It is the 6,613th most valuable company in the world and the 1,755th biggest in the United States. Its market cap has decreased by 28.94% in one year.
Market Cap
2.07B
Enterprise Value
1.50B
1-Year Change
-28.94%
Global Rank
Country Rank
#1,755 United States
Category
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.07B, an increase of 230.62%. That is a compound annual growth rate of 38.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.07B | -28.06% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.15B |
| Novavax | 2.13B |
| Viridian Therapeutics | 2.11B |
| Vericel | 2.07B |
| ADARx Pharmaceuticals | 2.02B |
| Palvella Therapeutics | 2.00B |
| Vir Biotechnology | 1.99B |
| Fortrea Holdings | 1.97B |